Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada
Clinical trial NCT06692881 · COMPLETED
Trial details
- NCT number
- NCT06692881
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-12
- Primary completion
- 2026-06-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.